» Articles » PMID: 27222010

Sympathetic Neural Signaling Via the β2-adrenergic Receptor Suppresses T-cell Receptor-mediated Human and Mouse CD8(+) T-cell Effector Function

Overview
Journal Eur J Immunol
Date 2016 May 26
PMID 27222010
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Postganglionic sympathetic neurons innervate secondary lymphoid organs and secrete norepinephrine (NE) as the primary neurotransmitter. NE binds and signals through five distinct members of the adrenergic receptor family. In this study, we show elevated expression of the β2-adrenergic receptor (ADRB2) on primary human CD8(+) effector memory T cells. Treatment of both human and murine CD8(+) T cells with NE decreased IFN-γ and TNF-α secretion and suppressed their cytolytic capacity in response to T-cell receptor (TCR) activation. The effects of NE were specifically reversed by β2-specific antagonists. Adrb2(-/-) CD8(+) T cells were completely resistant to the effects of NE. Further, the ADRB2-specific pharmacological ligand, albuterol, significantly suppressed effector functions in both human and mouse CD8(+) T cells. While both TCR activation and stimulation with IL-12 + IL-18 were able to induce inflammatory cytokine secretion, NE failed to suppress IFN-γ secretion in response to IL-12 + IL18. Finally, the long-acting ADRB2-specific agonist, salmeterol, markedly reduced the cytokine secretion capacity of CD8(+) T cells in response to infection with vesicular stomatitis virus. This study reveals a novel intrinsic role for ADRB2 signaling in CD8(+) T-cell function and underscores the novel role this pathway plays in adaptive T-cell responses to infection.

Citing Articles

Sympathetic nerve signaling rewires the tumor microenvironment: a shift in "microenvironmental-ity".

Sattler A, Korzun T, Gupta K, Diba P, Kyprianou N, Eksi S Cancer Metastasis Rev. 2025; 44(1):25.

PMID: 39831934 PMC: 11753337. DOI: 10.1007/s10555-025-10241-x.


CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy.

Yang P, Chen X, Yu F, Wang L, Li M, Bai Z J Immunother Cancer. 2024; 12(12).

PMID: 39653553 PMC: 11629019. DOI: 10.1136/jitc-2024-009910.


T cells with increased responsiveness cause obesity in mice without diet intervention.

Gregersen I, Kong X, Kooijman S, Foyn H, Grannes H, Olsen M iScience. 2024; 27(4):109471.

PMID: 38551005 PMC: 10973599. DOI: 10.1016/j.isci.2024.109471.


Pathological mechanisms of cold and mechanical stress in modulating cancer progression.

Hou Y, Yang X, He L, Meng H Hum Cell. 2024; 37(3):593-606.

PMID: 38538930 DOI: 10.1007/s13577-024-01049-y.


Inside the Biology of the β3-Adrenoceptor.

Pasha A, Tondo A, Favre C, Calvani M Biomolecules. 2024; 14(2).

PMID: 38397396 PMC: 10887351. DOI: 10.3390/biom14020159.


References
1.
Kasprowicz D, Kohm A, Berton M, Chruscinski A, Sharpe A, Sanders V . Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J Immunol. 2000; 165(2):680-90. DOI: 10.4049/jimmunol.165.2.680. View

2.
Lu B, Kwan K, Levine Y, Olofsson P, Yang H, Li J . α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol Med. 2014; 20:350-8. PMC: 4153835. DOI: 10.2119/molmed.2013.00117. View

3.
Lo D, Freedman J, Hesse S, Palmiter R, Brinster R, Sherman L . Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol. 1992; 22(4):1013-22. DOI: 10.1002/eji.1830220421. View

4.
Ramos H, Davis A, Cole A, Schatzle J, Forman J, Farrar J . Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates. Blood. 2009; 113(22):5516-25. PMC: 2689051. DOI: 10.1182/blood-2008-11-188458. View

5.
Tsuji T, Kato T, Kimata M, Miura T, Serizawa I, Inagaki N . Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells. Biol Pharm Bull. 2004; 27(10):1549-54. DOI: 10.1248/bpb.27.1549. View